894792-50-8

Basic information

• Product Name: 1,8-Naphthyridine-4-carboxylic acid, 2-phenyl-, ethyl ester
• Synonyms: 1,8-Naphthyridine-4-carboxylic acid, 2-phenyl-, ethyl ester
• CAS NO: 894792-50-8
• Molecular Formula: C₁₇H₁₄N₂O₂
• Molecular Weight: 278.30526
• Mol File: 894792-50-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,8-Naphthyridine-4-carboxylic acid, 2-phenyl-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1,8-Naphthyridine-4-carboxylic acid, 2-phenyl-, ethyl ester(894792-50-8)
• EPA Substance Registry System: 1,8-Naphthyridine-4-carboxylic acid, 2-phenyl-, ethyl ester(894792-50-8)

Safety Data

• Hazardous Substances Data: 894792-50-8(Hazardous Substances Data)

Usage

Chemical class

Naphthyridine carboxylic acid esters

Molecular weight

304.34 g/mol

Biological activity

Potential antimicrobial and anticancer properties

Applications

Building block in pharmaceutical synthesis, organic materials, reagent in organic synthesis, and fluorescent probe for biological processes

Ester form

Ethyl ester, allowing for easy manipulation and handling in laboratory settings

Versatility

Widely used in chemical and biological research due to its various applications and properties

Upstream product

• 64-17-5 ethanol 

Relevant articles and documents

SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE

The present invention relates to nitrogen-containing compounds according to formula (I) and pharmaceutically acceptable salts thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic ? cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.